28.7 C
Delhi
Monday, August 11, 2025

Dr Reddy Labs launches Lenalidomide Capsules in US

Date:

Share post:

Donate-GC-Razorpay

Mumbai: Dr. Reddy’s Labs on Thursday announced the launch of Lenalidomide Capsules in the US market, , a therapeutic equivalent generic version of REVLIMID (lenalidomide) Capsules approved by U. S. Food and Drug Administration (USFDA).

With this volume-limited launch, Dr. Reddy’s is eligible for first-to-market, 180 days of generic drug exclusivity for Lenalidomide Capsules in 2.5 mg and 20 mg strengths.

‘We are pleased with the first-to-market launch of two of our six strengths of Lenalidomide Capsules with 180-day market exclusivity,” says Marc Kikuchi, CEO, North America Generics, Dr. Reddy’s Laboratories.

“Bringing a more affordable generic version to market creates greater patient access for this important drug.’

Dr. Reddy’s Lenalidomide Capsules are available in strengths of 2.5 mg, 5 mg, and 10 mg, each in a bottle-count size of 28, as well as 15 mg, 20 mg, and 25 mg strengths, each in a bottle-count size of 21.

Related articles

Asim Munir’s Nuclear Threat in Tampa: “We Will Take Half the World Down With Us”

At a black-tie dinner in Tampa, Florida, organised to mark the retirement of the US Central Command (CENTCOM)...

Trump to meet Putin in Alaska next week

Washington: US President Donald Trump has said he’ll be meeting with Russian President Vladimir Putin next Friday in...

Police Launch Widespread Crackdown on Banned Literature in Kashmir

The Jammu and Kashmir Police, on Thursday, said that they carried out coordinated and legally sanctioned searches at...

J&K Govt Bans 25 Books ‘Propagating False Narratives, Secessionism’

With its latest notification dated Tuesday, August 5, the Home Department, Government of Jammu and Kashmir, declared the...